Patent Grant
7589081
The present invention relates to novel ligands for transition metals, to their preparation and to their use in catalytic reactions, especially for the improvement of haloaromatic compounds.
Haloaromatic compounds, including especially chloroaromatic compounds, are intermediates which can be used variously in the chemical industry and which serve as preliminary products for the production of agricultural intermediates, pharmaceuticals, colourings, materials, etc. Vinyl halides are also important intermediates which are used as starting materials for polymers and in the production of the above-mentioned products.
Catalysts which are frequently employed for the functionalisation of haloaromatic compounds or vinyl halides to aromatic olefins or dienes (Heck reaction, Stille reaction), biaryls (Suzuki reaction), alkynes (Sonogashira reaction), carboxylic acid derivatives (Heck carbonylation), amines (Buchwald-Hartwig reaction) are palladium catalysts and nickel catalysts. Palladium catalysts are generally advantageous, owing to the wide applicability of coupling substrates with in some cases good catalytic activities, while nickel catalysts have advantages in the field of the reaction of chloroaromatic compounds and vinyl chlorides. Moreover, nickel is more readily available than palladium.
Palladium and nickel catalysts used within the scope of the activation and further improvement of haloaromatic compounds are both palladium(II) and/or nickel(II) complexes as well as palladium(0) and/or nickel(0) complexes, although it is known that palladium(0) and nickel(0) compounds are the actual catalysts of the reaction. In particular, according to information in the literature, coordinatively-unsaturated 14- and 16-electron palladium(0) and nickel(0) complexes stabilised with donor ligands such as phosphanes are formulated as the active species.
When iodides are used as starting materials in coupling reactions it is also possible to dispense with phosphane ligands. However, aryl iodides and vinyl iodides are starting materials which are scarcely available and therefore very expensive, and their reaction additionally yields stoichiometric amounts of iodine salt waste products. If other starting materials are used in the Heck reaction, such as aryl bromides or aryl chlorides, the addition of stabilising and activating ligands is necessary if catalytically effective reaction of the starting materials is to be possible.
The catalyst systems described for olefinations, alkynylations, carbonylations, arylations, aminations and similar reactions frequently have satisfactory catalytic turnover numbers (TON) only with uneconomical starting materials such as iodoaromatic compounds and activated bromoaromatic compounds. Otherwise, in the case of deactivated bromoaromatic compounds and, especially, in the case of chloroaromatic compounds, large amounts of catalyst—usually more than 1 mol. %—must generally be added in order to achieve industrially usable yields (>90%). Moreover, owing to the complexity of the reaction mixtures, simple recycling of the catalyst is not possible, so that recovery of the catalyst also gives rise to high costs, which generally stand in the way of industrial implementation. Furthermore, it is undesirable to work with large amounts of catalyst, especially when preparing active ingredients or preliminary products for active ingredients, because catalyst residues otherwise remain in the product in this case.
More recent active catalyst systems are based on cyclopalladated phosphanes (W. A. Herrmann, C. BroBmer, K. Öfele, C.-P. Reisinger, T. Priermeier, M. Beller, H. Fischer, Angew. Chem. 1995, 107, 1989; Angew. Chem. Int. Ed. Engl. 1995, 34, 1844) or mixtures of sterically demanding arylphosphanes (J. P. Wolfe, S. L. Buchwald, Angew. Chem. 1999, 111, 2570; Angew. Chem. Int. Ed. Engl. 1999, 38, 2413) or tri-tert.-butylphosphane (A. F. Littke, G. C. Fu, Angew. Chem. 1998, 110, 3586; Angew. Chem. Int. Ed. Engl. 1998, 37, 3387) with palladium salts or palladium. complexes.
However, chloroaromatic compounds can generally not be activated in an industrially satisfactory manner even using these catalysts. Accordingly, in order to achieve high yields, comparatively large, amounts of catalyst must be used. Therefore, despite all the further developments which have been made to catalysts in recent years, only a small number of industrial reactions of the arylation, carbonylation, olefination, etc. of chloroaromatic compounds have hitherto become known.
For the mentioned reasons, the object underlying the present invention was to provide novel ligands and catalysts which are suitable for large-scale applications, are readily accessible and convert chloro- and bromo-aromatic compounds as well as corresponding vinyl compounds to the respective coupling products in high yield and with high purity, with high catalyst productivity.
This object is achieved according to the invention by novel phosphane ligands of formula (I)
wherein
The mentioned alkyl radicals have preferably from 1 to 10 carbon atoms, particularly preferably from 1 to 5. The alkenyl radicals have preferably from 2 to 10 carbon atoms, particularly preferably from 2 to 5. The cycloalkyl radicals have preferably from 3 to 8 carbon atoms. The aryl radicals have preferably from 6 to 10 carbon atoms, the heteroaryl radicals from 4 to 9.
Preference is given to ligands wherein X is CR2 and Y is CR9, yielding compounds of formula (II)
wherein the radicals R1 to R9 are as defined above. In a further preferred embodiment, X is nitrogen and Y is a CR9 group.
Preferred ligands of formula (I) or (II) carry at least one radical R1 selected from the group consisting of phenyl, C1-C10-alkyl, cyclopentyl, cyclohexyl, cycloheptyl, 1-adamantyl, 2-adamantyl, 5H-dibenzophospholyl, 9-phospha-bicyclo[3.3.1]nonanyl, 9-phosphabicyclo[4.2.1]nonanyl radicals. Examples of preferred C1-C10-alkyl- radicals are methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methyl-propyl, 1,1-dimethylethyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethyl-propyl, n-hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methyl-pentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethyl-butyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethyl-butyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, n-heptyl, n-octyl, n-nonyl, n-decyl, particular preference being given especially to the isopropyl radical and the tert-butyl radical.
Preferred radicals R2 to R9 are selected from the group hydrogen, C1-C10-alkyl, C2-C10-alkenyl, C1-C10-haloalkyl, C3-C8-cycloalkyl, C6-C10-aryl, which includes especially also phenyl, naphthyl, fluorenyl, and C2-C6-heteroaryl, wherein from 1 to 3 nitrogen atoms or an oxygen or sulfur atom may be present as hetero atom, and wherein two adjacent radicals R2 to R9 may be bridged with one another, there preferably being formed a 4- to 8-membered, preferably aromatic ring.
The ligands according to the invention can be prepared by reacting the corresponding phenylpyrrole derivative in the presence of a strong base, such as, for example, an alkyl-lithium compound, and subsequently adding a halophosphane, in accordance with the following reaction scheme, which is given by way of example
According to the invention, the novel phosphane ligands are used as catalysts in combination with transition metal complexes or transition metal salts of sub-group VIII of the periodic system of the elements, such as, for example, palladium, nickel, platinum, rhodium, iridium, ruthenium, cobalt. The ligands according to the invention can generally be added in situ to corresponding transition metal precursor compounds and accordingly used for catalytic applications. However, it may occasionally be advantageous for specific mono-, di-, tri- or tetra-phosphane complexes of the mentioned transition metals to be prepared first and subsequently used for catalysis reactions. The catalytic activity can thereby be increased further in some catalyst systems.
As transition metal compounds there are preferably used palladium or nickel compounds and particularly preferably palladium compounds.
The ligands according to the invention are generally added in situ preferably to nickel(II) or palladium(II) salts or to nickel(II), palladium(II) or nickel(0) or palladium(0) complexes. Preferred palladium complexes are, for example, palladium(II) acetate, palladium(II) chloride, palladium(II) bromide, lithium tetrachloropalladate(II), palladium(II) acetylacetonate, palladium(0) -dibenzylidene-acetone complexes, palladium(0) tetrakis(triphenyl-phosphane), palladium(0) bis(tri-o-tolylphosphane), palladium(II) propionate, palladium (II) bis(triphenyl-phosphane) dichloride, palladium(0) diallyl ether complexes, palladium(II) nitrate, palladium(II) chloride bis(acetonitrile), palladium(II) chloride bis(benzo-nitrile).
In catalytic applications, the phosphane ligand is generally used in excess relative to the transition metal. The ratio of transition metal to ligand is preferably from 1:1 to 1;1000. Ratios of transition metal to ligand of from 1:1 to 1:100 are particularly preferred. The exact transition metal/ligand ratio to be used depends on the concrete application, but also on the amount of catalyst used. Accordingly, it is generally customary to use low transition metal/ligand ratios at very low transition metal concentrations (<0.01 mol. %) than at transition metal concentrations of from 0.5 to 0.01 mol. % transition metal.
The catalysts are preferably used at temperatures of from 20 to 200° C.; in many cases, it has proved advantageous to work at temperatures of from 30 to 180° C., preferably from 40 to 160° C. The ligands can also be used without any loss of activity in reactions under pressure, reactions usually being carried out only up to a pressure of 100 bar, but preferably in the range of from normal pressure to 60 bar.
When carrying out catalytic reactions using ligands of formula (I), high turnover rates (TON) can be achieved with a low catalyst concentration. The transition metal is preferably used in a ratio of from 5 mol. % to 0.001 mol. %, particularly preferably from 0.5 mol. % to 0.01 mol. %, relative to the substrate.
The phosphane ligands prepared in accordance with the invention have proved suitable especially as the ligand component for the catalytic preparation of arylated olefins (Heck reactions), biaryls (Suzuki reactions), α-aryl ketones and amines from aryl halides or vinyl halides. However, it is obvious to the person skilled in the art that the novel catalyst systems can also be used to catalyse other transition-metal-catalysed reactions, such as metathesis or hydrogenations of double bonds or carbonyl compounds, but especially palladium- and nickel-catalysed carbonylations of aryl halides, alkynylations using alkynes (Sonogashira couplings), cross-couplings using organometallic reagents, such as, for example, zinc reagents or tin reagents.
A particular advantage of the ligands according to the invention is the high degree of activity induced by the ligands in the activation of readily available but inert chloroaromatic compounds. The described catalyst and ligand systems can accordingly be used for large-scale purposes.
The phosphanes prepared in accordance with the invention can be used in the preparation of aryl olefins, dienes, diaryls, benzoic acid derivatives, acrylic acid derivatives, arylalkanes, alkynes, amines. The compounds so prepared are used, for example, as UV absorbers, as intermediates for pharmaceuticals and agrochemicals, as ligand precursors for metallocene catalysts, as perfumes, as active ingredients having biological activity and as structural units for polymers.
General
Reactions of compounds sensitive to air were carried out in an argon-filled glove-box or in standard Schlenk tubes. The solvents tetrahydrofuran (THF), diethyl ether and dichloromethane were degassed and rendered absolute by means of a solvent-drying installation (Innovative Technologies) by filtration through a column packed with activated aluminium oxide. Toluene and pentane were additionally freed of oxygen using a column packed with a copper catalyst.
The Examples which follow serve to explain the invention without limiting it thereto.
Preparation of Ligands 1 to 3 (L1 to L3):
10 mmol. of phenylpyrrole are dissolved under argon in 20 ml of absolute hexane. 10 mmol. of TMEDA and 10 mmol. of n-BuLi (1.6 M in hexane) are added at room temperature. After three hours' heating under reflux, a yellow suspension is obtained. It is cooled to room temperature, and 10 mmol. of C1-PR12 are slowly added thereto. After reacting for one hour under reflux, hydrolysis is carried out at room temperature using 15 ml of degassed water. The organic phase is transferred to a separating funnel, under argon, with the aid of a cannula. The aqueous phase is extracted twice using 15 ml of hexane each time. The hexane fractions are likewise transferred to the separating funnel. The combined organic phases are washed with 15 ml of degassed water and dried over degassed sodium sulfate. The solvents are distilled off and the viscous residue is dissolved in methanol with heating. After one day at room temperature, the mixture is cooled for four hours at 0° C. The resulting white solid is filtered off and dried in vacuo (purity 90-95%).
Yields:
1.25 mmol. of phenylboronic acid and 2.00 mmol. of base are weighed into 2.5 ml glass bottles. These bottles are purged with argon and sealed. All further stock solutions are prepared under argon.
The following solutions are mixed under Ar and stirred for about 1 hour at room temperature (reaction metal precursor with ligand):
A Vantage synthesizer is used to pipette the following amounts of the resulting solutions into the Vantage vials:
Using the Vantage mixing/heating unit, the Vantage vials so filled are heated for 4.0 hours at 110° C. (Vantage setting) with shaking (1000 rpm) (heating phase 0.5 h/internal temperature about 120° C.).
After the reaction, 1.0 ml of each reaction solution is filtered over silica gel. The solution so obtained is analysed by means of GC. The yields of the individual conversions are summarised in Table 1.
Suzuki Reaction of Aryl Chlorides with Phenylboronic Acid/-pyrrolylphosphanes
R—Ar—Cl+PhB(OH)2→R—Ar—Ph
Reagents: 3 nmol. of ArCl, 4.5 mmol. of PhB(OH)2, 6 mmol. of K3PO4, Pd(OAc)2, Pd/L=1:2, 6 ml of toluene, 20 hours. The reaction is carried out as a one-pot reaction under protecting gas. Working-up is carried out with 10 ml of each of methylene chloride and 1N sodium hydroxide solution. The reaction is monitored by means of GC, internal GC standard: hexadecane.
The starting materials used and the results of the conversions are summarised in Table 2.
a)unknown (not visible in the GC) decomposition products. Both starting material and product withstand the basic working-up undamaged. Decomposition (>60%) but scarcely any product (<10%) is observed even at a reaction temperature of 60° C.
1.6 ml of TMEDA (15 mmol.) are added to a suspension of 1.43 g (10 mmol.) of N-phenylpyrrole in 30 ml of hexane. 6.25 ml of 1.6 molar n-butyllithium solution (10 mmol.) are added at room temperature. The mixture is then heated for 2.5 hours at reflux temperature (solution 1). In another flask, 3.36 g (10 mmol.) of di-1-adamantylchlorophosphane are mixed with 40 ml of hexane and heated to 76° C. (solution 2). The boiling solution 1 is then slowly transferred into solution 2, which is at 76° C., by means of a cannula. The mixture is then boiled for a further 2 hours at reflux, the solution is cooled, and 20 ml of water are added thereto. The organic phase is filtered off over magnesium sulfate. The solution is concentrated in vacuo; 15 ml of toluene are added thereto, and the mixture is heated to 60° C. and then cooled. After one day at room temperature, the product is filtered off. Yield: 3.3 g (75%).
31P NMR (161 MHz, CDCl3): δ=−4.5.
1H NMR (400 MHz, CDCl3): δ=1.7 (bs, 16H), 1.7-2.0 (m, 22H), 6.4 (dd, J1=8.6, 12.8, J2=3.5, 1H), 6.75 (dd, J1=3.5, J2=1, 1H), 6.9-7.0 (m, 1H), 7.25-7.3 (m, 2H), 7.35-7.45 (m, 3H).
13C NMR (100.6 MHz, CDCl3): δ=28.6 (d, JPC=11.5), 37, 37.5 (d, JPC=17.2), 41.6 (d, JPC=11.5), 108.2, 119.5 (d, JPC=4.7), 125.8, 126 (d, JPC=10.8), 127.3, 128.2, 128.3 (d, JPC=3.8), 141.6 (d, JPC=1.9).
MS: m/z (%): 443 (68), 308 (13), 172 (14), 135 (100), 107 (7), 93 (19), 79 (17).
HRMS: C30H38NP: calc. 443.2742; found 443.26775.
1.6 ml of TMEDA (15 mmol.) are added to a suspension of 1.86 g (10 mmol.) of N-mesitylimidazole in 30 ml of hexane. 6.25 ml of 1.6 molar n-butyllithium solution (10 mmol.) are added at room temperature. The mixture is then heated for 2.5 hours at reflux temperature (solution 1). In another flask, 2.2 ml (10 mmol.) of dicyclohexylchlorophosphane are mixed with 20 ml of hexane and heated to 60° C. (solution 2). The boiling solution 1 is then slowly transferred into solution 2, which is at 60° C., by means of a cannula. The mixture is then boiled for a further 1 hour at reflux, the solution is cooled, and 20 ml of degassed water are added thereto. The organic phase is filtered off over magnesium sulfate. The solution is concentrated in vacua; 30 ml of pentane are added thereto, and the mixture is boiled for 1 hour at reflux. The product precipitates in crystalline form at −30° C. and is filtered off while cold. Yield: 2.48 g (65%)
31P NMR (161 MHz, CDCl3): δ=−18.9.
1H NMR (400 MHz, CDCl3): δ=0.9-1.2 (m, 11H), 1.5-1.7 (m, 11H), 1.9 (s, 6H), 1.9-2.0 (m, 2H), 2.2 (s, 3H), 6.8-6.9 (m, 3H), 7.3 (S, 1H).
13C NMR (100.6 MHz, CDCl3): δ=18.5, 20.9, 26.9, 27.5, 27.7 (d, J=9.5), 30.4 (d, J=14.3), 30.9 (d, J=10.5), 34.6 (d, J=9.5), 122.7, 129.2, 131.5, 134.9, 135.5, 138.2, 147.5 (d, J=16.2).
MS; m/z (%): 382 (11), 299 (100), 217 (24), 202 (7), 185 (27), 83 (7), 55 (21).
Lit.: Faigl, F.; Fogassy, K.; Thuner, A.; Toke, L.; Tetrahedron 1997, 53, 4883.
10.95 g (83 mmol.) of 1 and 4.7 g (38 mmol.) of 2 are refluxed for 2 hours in 10 ml of glacial acetic acid. The colour of the solution changes from yellow through red to black. The mixture is then diluted with 75 ml of distilled water and extracted twice with 100 ml of CH2Cl2. Na2CO3 is added to the black organic solutions. After filtration and concentration (20 mbar, 50° C.), a black oil is obtained and is distilled in vacuo. Yield: 4.45 g (25.7 mmol.; 75%).
1H NMR (25° C., CDCl3): δ (ppm)=3.8 (s, 3H), 6.3 (t, J=2.2 Hz, 2H), 7.0 (m, 4H), 7.3 (m, 2H).
3.14 ml (15 mmol.) of N,N,N′,N′,N″-pentamethyldiethylene-triamine (PMDTA) are added to a solution of 1.73 g (10 mmol.) of 1 in 30 ml of hexane. A solution (1.6 M in hexane) of n-BuLi (6.25 ml, 10 mmol.) is added dropwise. After 3 hours under reflux (75° C.), the colour of the solution has changed from yellow to black. Without cooling this mixture, 2.2 ml (10 mmol.) of chlorodicyclohexyl-phosphane dissolved in 20 ml of hexane are added dropwise. Refluxing is carried out for a further one hour. The colour of the solution lightens to orange, and a white precipitate forms. After cooling to room temperature, 30 ml of water are added to the mixture. The orange organic phase is extracted 3 times using 20 ml of hexane each time. The combined organic phases are washed with 10 ml of water and filtered over Na2SO4. The solvent is removed in vacuo (45° C.). The viscous orange residue is refluxed for 30 minutes in 30 ml of MeOH. On cooling to RT, the product precipitates and is filtered off (1.1 g, 30%).
1H NMR (25° C., C6D6): δ (ppm)=1.1-1.9 (m, 22H), 3.2 (s, 3H), 7.0 (m, 4H), 6.5-7.2 (m, 3H).
13C NMR (25° C., C6D6): δ (ppm)=27.2, 27.7, 27.8, 29.6, 30.9, 34.9, 55.1, 109.8, 111.8, 116.5, 116.6, 120.2, 123.6, 129.3, 130.9, 136.3, 156.0.
31p NMR (25° C., C6D6): δ (ppm) −26.8.
Lit.: Synthesis: Klapars, A.; Antilla, J.; Huang, X.; Buchwald, S. J. Am. Chem. Soc. 2001, 123, 7721. Analysis: (a) Nishio, T. J. Org. Chem. 1988, 53, 1323. (b) Belier, M.; Breindl, C.; Riermeier, T.; Tillack, A. J. Org. Chem. 2001, 66, 1403.
0.19 g (0.1 nmol.) of CuI, 2.34 g (20 mmol.) of 1, 8.82 g (42 mmol.) of K3PO4, 0.48 ml (4 mmol.) of 1,2-diaminocyclo-hexane and 3.16 ml (30 mmol.) of 2 are stirred for 24 hours at 110° C. in 20 ml of dry dioxane. The mixture is then diluted with 50 ml of ethyl acetate. The violet precipitate is filtered off over silica gel, yielding a yellow solution, which is concentrated in vacuo (20 mbar, 50° C.). The orange oil that remains is purified by column chromatography (silica gel, hexane/ethyl acetate 98/2). Yield: 3.0 g (15.5 mmol.; 75%).
1H NMR (25° C., CDCl3): δ (ppm)=6.45 (m, 1H), 6.9-7.5 (m, 10H).
13C NMR (25° C., CDCl3): δ (ppm)=104.1, 111.1, 120.9, 121.7, 122.9, 124.9, 126.9, 128.5, 129.9, 130.1, 130.6, 132.1, 136.4, 140.3.
1.6 ml (15 mmol.) of TMEDA are added to 1.93 g (10 mmol.) of 1 in 30 ml of hexane. A solution (1.6 M in hexane) of n-BuLi (6.25 ml, 10 mmol.) is added dropwise. After 3 hours, reflux (75° C.), the colour has deepened from yellow to orange. Without cooling, a solution of 2.2 ml (10 mmol.) of chlorodicyclohexylphosphane in 20 ml of hexane is added dropwise. Refluxing is carried out for a further one hour, the colour of the mixture lightening again and a white solid precipitating. After cooling, 30 ml of water are added to the mixture. The aqueous phase is extracted 3 times using 20 ml of hexane each time. The combined organic phases are washed with 10 ml of water, dried over Na2SO4 and concentrated in vacuo (45° C.). The yellow residue is boiled for 30 minutes in 30 ml of MeOH. After cooling to RT, the resulting product is filtered off (660 mg, 17%).
31P NMR (25° C., C6D6): δ (ppm)=−24.8.
Lit.: Analysis: (a) Paredes, E.; Biolatto, B.; Kneeteman, M.; Mancini, P. Tetrahedron Lett. 2000, 41, 8079. (b) Gross, H. Chem. Ber. 1962, 95, 2270.
10.95 g (83 mmol.) of 1 are added to a violet solution of 5.44 g (38 mmol.) of 2 in 10 ml of glacial acetic acid. The resulting brown solution is refluxed for 3 hours under argon (120° C.), whereupon its colour changes to black. The solution is concentrated to half the volume in vacuo (20 mbar, 50° C.) before being hydrolysed with 20 ml of water. The organic phase is extracted with CH2Cl2 (3×30 ml), dried over Na2SO4 and concentrated (20 mbar, 50° C.), there being obtained a black oil which is purified by column chromatography (silica gel, hexane/ethyl acetate 85/15). Yield: 3.53 g (18.3 mmol.) of a red oil which, crystallises at −25° C. (pink crystals).
1H NMR (25° C., CDCl3): δ (ppm)=6.3 (t, J=2.2 Hz, 2H), 6.7 (t, J=2.2 Hz, 2H), 6.9-7.2 (m, 4H), 7.3 (d, 8.1 Hz, 1H), 7.4 (d, 8.1 Hz, 1H), 7.7 (d, 8.1 Hz, 1H).
13C NMR (25° C., CDCl3): δ (ppm)=110.0, 123.6, 123.8, 123.9, 125.7, 126.9, 127.4, 128.2, 130.7, 134.9, 139.0.
Elemental analysis: found (%) C 86.7 (th: 87.0), H 5.89 (5.70), N 7.29 (7.30).
1.6 ml (15 mmol.) of TMEDA are added to a solution of 1.93 g (10 mmol.) of 1 in 30 ml of hexane. A solution (1.6 M in hexane) of n-BuLi (6.25 ml, 10 mmol.) is added dropwise. After 3 hours reflux (75° C.), the colour has changed from orange through green to black. Without cooling, a solution of 2.2 ml (10 mmol.) of chlorodicyclo-hexylphosphane in 20 ml of hexane is added dropwise and refluxing is carried out for a further one hour. The colour of the solution changes to yellow, and a white precipitate forms. After cooling to RT, 30 ml of water are added to the mixture. The aqueous phase is extracted 3 times using 20 ml of hexane each time. The combined organic phases are washed with 10 ml of water, dried over Na2SO4 and concentrated in vacuo (45° C.). The orange oil that remains is refluxed for 30 minutes in 30 ml of MeOH (60° C.). On cooling to −25° C., the product precipitates in the form of a yellow solid and is filtered off (0.9 g, 24%).
31p NMR (25° C., C6D6): δ (ppm)=−23.3.
General Procedure:
In a three nacked 100 ml round bottom flask with reflux condenser, N-arylpyrrole (or N-arylindole or N-arylimidazole) (10 mmol) was dissolved in 20 ml of freshly distilled n-hexane under argon. TMEDA (15 mmol) was added followed by n-BuLi (10 mmol, 1.6 M in hexane) at room temperature. The reaction mixture was refluxed for 3 h. A solution of the corresponding chlorophosphine (10 mmol in 5 ml hexane) was slowly added via syringe. The mixture was further refluxed for 1 h. After cooling to room temperature, degassed water (15 ml) was added and the mixture was stirred to get a clear solution. The aqueous layer was extracted with hexane (2×15 ml) and the combined organic layers were washed with degassed water (15 ml). The solution was dried over Na2SO4 and concentrated at 45° C. to get a viscous liquid which was recrystallized from methanol or toluene.
A 30 mL pressure tube was loaded with Pd(OAc)2 (0.025 mol), the ligand (0.050 mmol), NaOtBu (6.0 mmol) and was purged by argon for 30 minutes. Then, were successively added under argon, toluene (5 mL), the aryl chloride (5 mmol) and the amine (6 mmol). The mixture was stirred under argon at 120° C. for 20 hours. After reaction, it was diluted with diethylether (15 mL) and washed with water (10 mL). After extraction, the organic phase was dried over MgSO4, concentrated under vacuum and the final product was isolated by column chromatography (silicagel, hexane/ethyl acetate 90/10). Alternatively, diethyleneglycol-di-n-butylether or hexadecane was added as internal standard, and quantitative analysis was done by gas chromatography.
[a]Average of 2 runs, determined by GC using diethyleneglycol di-n-butyl ether as internal standard.
[a]Average of 2 runs, determined by GC using diethyleneglycol di-n-butyl ether or hexadecane as internal standard.
[b]The reaction was conducted within 48 hours.
[c]Ligand 5 was used (2 equiv/Pd).
[a]Average of 2 runs, determined by GC using diethyleneglycol di-n-butyl ether or hexadecane as internal standard.
[b]1 mol % Pd(OAc)2, 2 mol % ligand.
[a]Average of 2 runs, determined by GC using diethyleneglycol di-n-butyl ether as internal standard.
[a]Average of 2 runs, determined by GC using diethyleneglycol di-n-butyl ether or hexadecane as internal standard.
[b]1 mol % Pd(OAc)2, 2 mol % ligand.
| Number | Date | Country | Kind |
|---|---|---|---|
| 103 22 408 | May 2003 | DE | national |
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/EP2004/004644 | 5/3/2004 | WO | 00 | 10/27/2005 |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2004/101581 | 11/25/2004 | WO | A |
| Number | Date | Country |
|---|---|---|
| 02055528 | Jul 2002 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 20070123707 A1 | May 2007 | US |
